This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moore, P. F. Articles by Naydan, D. Search for Related Content PubMed PubMed Citation Articles by Moore, P. F. Articles by Naydan, D.

American Journal of Pathology, Vol 148, 1699-1708, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules

PF Moore, MD Schrenzel, VK Affolter, T Olivry and D Naydan
Department of Pathology, Microbiology, School of Veterinary Medicine, University of California, Davis 95616, USA.

Canine cutaneous histiocytoma (CCH) is a common, benign neoplasm of the dog. Histiocytomas most commonly occur as solitary lesions that undergo spontaneous regression. The age-specific incidence rate for histiocytomas drops precipitously after 3 years, although histiocytomas occur in dogs of all ages. Langerhans cells (LCs) in humans and dogs express abundant major histocompatibility complex class II molecules and a variety of leukocyte antigens characteristic of dendritic cell differentiation including CD1a, CD1b, CD1c, and CD11c. The immunophenotype of CCH resembled that of cutaneous LCs by virtue of the expression of CD1 molecules (CD1a, -b, and -c), CD11c, and major histocompatibility complex class II. Furthermore, histiocytoma cells had a tropism for epidermis, which was also consistent with an epidermal LC lineage. The expression of adhesion molecules such as CD11b (variable), CD44, CD54 (ICAM-1), and CD49d (VLA-4) in CCH indicated that the infiltrating cells had some of the characteristics of activated LCs, as these molecules are not expressed by normal, resting canine epidermal LCs. CCH did not express Thy-1 or CD4. Thy-1 expression is a characteristic of human and canine dermal dendrocytes, which are perivascular dendritic antigen-presenting cells closely related to epidermal LCs. CD4 expression is prevalent in human LC histiocytosis, and in this respect CCH differed from human LC histiocytosis. Here we demonstrate that CCH is a localized form of self- limiting LC histiocytosis, which predominantly expresses an epidermal LC phenotype. CCH occurs as solitary or, less commonly, as multiple cutaneous nodules or plaques, which rarely may extend beyond the skin to local lymph nodes. Regression of CCH occurs spontaneously in the vast majority of cases in primary and secondary sites, and is mediated by CD8+ alpha beta T cells. The high frequency of CCH within the general canine population offers the potential that the dog may provide an interesting model system to further the understanding of LC proliferative disorders, particularly the self-limiting, cutaneous form of human LC histiocytosis.

This article has been cited by other articles:

				S. J. Baines, E. F. McInnes, and I. McConnell E-cadherin expression in canine cutaneous histiocytomas Vet Rec., April 19, 2008; 162(16): 509 - 513. [Abstract] [Full Text] [PDF]

				P. F. Moore, V. K. Affolter, and W. Vernau Canine Hemophagocytic Histiocytic Sarcoma: A Proliferative Disorder of CD11d+ Macrophages. Vet. Pathol., September 1, 2006; 43(5): 632 - 645. [Abstract] [Full Text] [PDF]

				V. K. Affolter and P. F. Moore Feline progressive histiocytosis. Vet. Pathol., September 1, 2006; 43(5): 646 - 655. [Abstract] [Full Text] [PDF]

				N. J. Fernandez, K. H. West, M. L. Jackson, and B. A. Kidney Immunohistochemical and Histochemical Stains for Differentiating Canine Cutaneous Round Cell Tumors Vet. Pathol., July 1, 2005; 42(4): 437 - 445. [Abstract] [Full Text] [PDF]

				L. E. Craig, M. E. Julian, and J. D. Ferracone The Diagnosis and Prognosis of Synovial Tumors in Dogs: 35 Cases Vet. Pathol., January 1, 2002; 39(1): 66 - 73. [Abstract] [Full Text] [PDF]

				V. K. Affolter and P. F. Moore Localized and Disseminated Histiocytic Sarcoma of Dendritic Cell Origin in Dogs Vet. Pathol., January 1, 2002; 39(1): 74 - 83. [Abstract] [Full Text] [PDF]

				C. Fournel-Fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont, L. Chabanne, T. Marchal, J. L. Cadore, I. Goy-Thollot, D. Ledieu, et al. Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases Vet. Pathol., January 1, 2002; 39(1): 92 - 109. [Abstract] [Full Text] [PDF]

				S.M. Rhind CD1--The Pathology Perspective Vet. Pathol., November 1, 2001; 38(6): 611 - 619. [Abstract] [Full Text] [PDF]

				C. C. Dascher, K. Hiromatsu, J. W. Naylor, P. P. Brauer, K. A. Brown, J. R. Storey, S. M. Behar, E. S. Kawasaki, S. A. Porcelli, M. B. Brenner, et al. Conservation of a CD1 Multigene Family in the Guinea Pig J. Immunol., November 15, 1999; 163(10): 5478 - 5488. [Abstract] [Full Text] [PDF]